๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer

โœ Scribed by Merrill S. Kies; Steven T. Rosen; Tat-Kin Tsang; Ramananda Shetty; Philip A. Schneider; Carl B. Wallemark; Thomas W. Shields


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
511 KB
Volume
60
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Chemotherapy of the squamous cell lung c
โœ Efstathios Tapazoglou; Lisa Polin; Thomas H. Corbett; Muhyi Al-Sarraf ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer US ๐ŸŒ English โš– 403 KB

The combination of Cis-dichlorodiammineplatinum (II) (CisDDPt) + 5-Fluorouracil (5-FU) was compared with two CisDDPt analogues + 5-FU [Iproplatin (CHIP) + 5-FU and Carboplatin (CBDCA) + 5-FU] for relative efficacy against advanced stage squamous cell lung tumors (LC-12) in Balb/c mice. At equitoxic

Cisplatin-5-fluorouracil chemotherapy fo
โœ Johnson, Jonas T. ;Mayernik, David G. ;Myers, Eugene N. ;Nolan, Teresa A. ;Schra ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Wiley (John Wiley & Sons) โš– 368 KB ๐Ÿ‘ 2 views

Patients with locally advanced, inoperable squamous cell carcinoma of the head and neck were offered three courses of cisplatin and 96-h 5-fluorouracil (5-FU) infusion. Subsequent therapy included surgery when feasible, irradiation therapy, and a maintenance program of methotrexate (MTX)-5-FU. Thirt